Echo Therapeutics Inc fka ECTE

[ramad]

Investor most likely wanted a change in management because they were slow in their progress in developing a workable CGM and did not want to continue bailing out capital to echo to keep their doors open. Echo and MTIA will work together what they have now and will not need a ceo until Mtia believes echo has a product that will be submitted for clinical trials. Decisions by management and by the board as everyone knows were not favorable on the past year or possibly echo and mtia were not on the same page. The investor has the upper hand and could have stipulated any more money to echo their has to be management changes and or other reasons the shareholders are not privy to that was between echo and mtia.